Reticulated Platelet Values in Controls and Thrombocytosis Patients
. | Controls (n = 83) . | Chronic Primary Thrombocytosis . | Chronic Secondary Thrombocytosis . | Transient Thrombocytosis . | |||
---|---|---|---|---|---|---|---|
No Thrombosis (n = 5) . | Thrombosis (n = 7) . | No Thrombosis (n = 18) . | Thrombosis (n = 7) . | No Thrombosis (n = 40) . | Thrombosis (n = 6) . | ||
Platelet count (×109/L) | 251 ± 88 | 855 ± 163 | 802 ± 97 | 691 ± 74 | 914 ± 249 | 687 ± 110 | 719 ± 96 |
RP% | 3.4% ± 1.3% | 4.2% ± 1.9% | 13.8% ± 5.1%* | 3.1% ± 1.6% | 16.7% ± 13.8%† | 4.5% ± 2.7% | 11.5% ± 4.4%† |
ARP (×109/L) | 6 ± 6 | 36 ± 14 | 94 ± 33* | 28 ± 10 | 114 ± 68† | 35 ± 16 | 90 ± 46† |
. | Controls (n = 83) . | Chronic Primary Thrombocytosis . | Chronic Secondary Thrombocytosis . | Transient Thrombocytosis . | |||
---|---|---|---|---|---|---|---|
No Thrombosis (n = 5) . | Thrombosis (n = 7) . | No Thrombosis (n = 18) . | Thrombosis (n = 7) . | No Thrombosis (n = 40) . | Thrombosis (n = 6) . | ||
Platelet count (×109/L) | 251 ± 88 | 855 ± 163 | 802 ± 97 | 691 ± 74 | 914 ± 249 | 687 ± 110 | 719 ± 96 |
RP% | 3.4% ± 1.3% | 4.2% ± 1.9% | 13.8% ± 5.1%* | 3.1% ± 1.6% | 16.7% ± 13.8%† | 4.5% ± 2.7% | 11.5% ± 4.4%† |
ARP (×109/L) | 6 ± 6 | 36 ± 14 | 94 ± 33* | 28 ± 10 | 114 ± 68† | 35 ± 16 | 90 ± 46† |